WeChat Mini Program
Old Version Features

BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial.

Roger A Fielding, Michael M Dao, Kevin Cannon, Moise Desvarieux, Sam S Miller, Michael Paul Gimness, Donald M Brandon,Dennis T Villareal,Olivier Bruyere,Ivan Bautmans, Kyle Rickner,Robert Perry,Stephen B Kritchevsky,Nicolas Musi, Joe M Chehade, Judith L Kirstein,Evelien Gielen, Paul Pickrell, Pierre Dilda,Rene Lafont, Carole Margalef,Yves Rolland,Susanna Del Signore,Jean Mariani,Samuel Agus,Cendrine Tourette,Waly Dioh,Rob van Maanen,Stanislas Veillet

Journal of cachexia, sarcopenia and muscle（2025）

Cited 0|Views1
Key words
20‐hydroxyecdysone,BIO101,clinical trial,gait speed,mobility disability,sarcopenia
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined